Adherence to heart failure quality-of-care indicators in US hospitals - Analysis of the ADHERE Registry

被引:204
作者
Fonarow, GC
Yancy, CW
Heywood, JT
机构
[1] Univ Calif Los Angeles, Div Cardiol, Cardiomyopathy Ctr, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Texas, SW Med Ctr, Div Cardiol, Dallas, TX USA
[3] Loma Linda Univ, Med Ctr, Loma Linda, CA 92350 USA
关键词
D O I
10.1001/archinte.165.13.1469
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Quality-of-care indicators have been developed for patients hospitalized with heart failure. However, little is known about current rates of conformity with these indicators or their variability across hospitals. Methods: Data from 81142 admissions occurring between July 1, 2002, and December 31, 2003, at 223 academic and nonacademic hospitals in the United States participating in the Acute Decompensated Heart Failure National Registry (ADHERE) were analyzed. Rates of conformity with the 4 joint Commission on Accreditation of Healthcare Organizations core performance measures-discharge instructions (HF-1), assessment of left ventricular function (HF-2), use of angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction (HF-3), and smoking cessation counseling (HF-4)-as well as length of stay and in-hospital mortality rates were computed. Results: Across all hospitals, the median rates of conformity with HF-1, HF-2, HF-3, and HF-4 were 24.0%, 86.2%, 72.0%, and 43.2%, respectively. Rates of conformity at individual hospitals varied from 0% to 100%, with statistically significant differences between academic and nonacademic hospitals. Statistically significant positive independent predictors of overall conformity included the prevalence of comorbidities and the use of more intense pharmacologic management. Median hospital length of stay varied from 2.3 to 9.5 days, and in-hospital mortality varied from 0% to 11.1%. Conclusions: Among hospitals providing care for patients with heart failure, there is significant individual variability in conformity to quality-of-care indicators and clinical outcomes and a substantial gap in overall performance. Establishing educational initiatives and quality improvement systems to reduce this variability and eliminate this gap would be expected to substantially improve the care of these patients.
引用
收藏
页码:1469 / 1477
页数:9
相关论文
共 30 条
[1]   Use and monitoring of "statin" lipid-lowering drugs compared with guidelines [J].
Abookire, SA ;
Karson, AS ;
Fiskio, J ;
Bates, DW .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (01) :53-58
[2]   Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE) [J].
Adams, KF ;
Fonarow, GC ;
Emerman, CL ;
LeJemtel, TH ;
Costanzo, MR ;
Abraham, WT ;
Berkowitz, RL ;
Galvao, M ;
Horton, DP .
AMERICAN HEART JOURNAL, 2005, 149 (02) :209-216
[3]  
Aghababian Richard V, 2002, Rev Cardiovasc Med, V3 Suppl 4, pS3
[4]  
*AM HEART ASS AM S, 2005, HEART DIS STROK STAT
[5]   A qualitative study of increasing β-blocker use after myocardial infarction -: Why do some hospitals succeed? [J].
Bradley, EH ;
Holmboe, ES ;
Mattera, JA ;
Roumanis, SA ;
Radford, MJ ;
Krumholz, HM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (20) :2604-2611
[6]   Relation of inflammation and benefit of statins after percutaneous coronary interventions [J].
Chan, AW ;
Bhatt, DL ;
Chew, DP ;
Reginelli, J ;
Schneider, JP ;
Topol, EJ ;
Ellis, SG .
CIRCULATION, 2003, 107 (13) :1750-1756
[7]   Guidelines for acute decompensated heart failure treatment [J].
DiDomenico, RJ ;
Park, HY ;
Southworth, MR ;
Eyrich, HM ;
Lewis, RK ;
Finley, JM ;
Schumock, GT .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (04) :649-660
[8]   Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): Rationale and design [J].
Fonarow, GC ;
Abraham, WT ;
Albert, NM ;
Gattis, WA ;
Gheorghiade, M ;
Greenberg, B ;
O'Connor, CM ;
Yancy, CW ;
Young, J .
AMERICAN HEART JOURNAL, 2004, 148 (01) :43-51
[9]  
Fonarow GC, 2003, CIRCULATION, V108, P721
[10]   Improved treatment of coronary heart disease by implementation at a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) [J].
Fonarow, GC ;
Gawlinski, A ;
Moughrabi, S ;
Tillisch, IH .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (07) :819-822